List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 2 studies with search of:   "Cellgate" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Safety Study of 16.5mg (3.3%) CGC-11047 Injected Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to Age Related Macular Degeneration
Condition: Age Related Macular Degeneration
Intervention: Drug: CGC-11047 3.3% (16.5mg)
2 Suspended Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: CGC-11047

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services